http://www.xencor.com
Xencor, Inc. Company Intro
Senior Vice President, Research & Chief Scientific Officer
Industry
Healthcare
Xencor, Inc. Headquaters
111 West Lemon Avenue
Monrovia,91016
United States
Xencor, Inc. Share price
15 Jan 2021 02:52 GMT
$48.00
0.06 (0.13 %)
Xencor, Inc. Market cap
$2.841 B
WMC RANKING
2021
Xencor, Inc. # 46
BiotechnologyLatest Xencor, Inc. News
08 Jan 2021
Global Allergic Conjunctivitis Drug Market (2021) to Witness Huge Growth by 2026 | Accolade Pharmaceuticals LLC, Aldeyra Therapeutics Inc, AlleCures Inc, Allergan Plc, Clevexel Pharma SAS
Ocular Therapeutix Inc; Ohr Pharmaceutical Inc; Portola Pharmaceuticals Inc; Re-Pharm Ltd; Realm Therapeutics Plc; Sylentis SAU; Xencor Inc. Get Sample Copy ...
08 Jan 2021
Global Bispecific Antibody Therapeutics Market Is Expected To Gain Market Growth In The Forecast Period Of 2020 To 2027||Amgen Inc, AstraZeneca, , Sanofi, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc
... Of 2020 To 2027||Amgen Inc, AstraZeneca, , Sanofi, F. Hoffmann-La Roche Ltd, ... Roche Ltd, Regeneron Pharmaceuticals Inc, Eli Lilly and Company, Xencor, ...
08 Jan 2021
The Daily Biotech Pulse: Sarepta Gene Therapy Study ...
Intellia Therapeutics Inc (NASDAQ: NTLA) (the genomic editing company announced ... Xencor Inc (NASDAQ: XNCR) (announced a cancer drug collaboration).
WMC Market Score
WMC Market to Revenue Score
Xencor, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Xencor, Inc. | USD | $156,700 | $142,876 | $26,875 | $28,410B | 46 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $552,640B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $342,630B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $588,000B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $279,490B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Xencor, Inc. Social Followers vs Top 4 Industry Competitors
Xencor, Inc. Post vs Top 4 Industry Competitors
Xencor, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Xencor, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Xencor, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Xencor, Inc. | 1.70 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 65.98 | 28.72 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.08 | 100 | 60 | 0 | 0 | 90.49 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.81 | 86 | 0 | 0 | 99.97 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
